Total Funding
$1.1B
Employee Range
11-50
HAYA Therapeutics is a developer of RNA-based therapeutics created to treat heart failure. The company's therapeutics utilizes biopharmaceutical therapy to target a heart specific regulator of fibrosis, the long noncoding RNA, enabling physicians to to block myocardial fibrosis and treat heart failure.
HAYA Therapeutics data powered by:
Share
HAYA Therapeutics data powered by:
HAYA TherapeuticsOverall Ranking
Regional Rank
Share
Loading...
In Western Europe
Top null%out of exits
HAYA TherapeuticsIndustry Rankings in
Healthtech
City Rank
Share
Loading...
In Lausanne
Top null%out of exits
National Rank
Share
Loading...
In Switzerland
Top null%out of exits
Regional Rank
Share
Loading...
In Western Europe
Top null%out of exits
HAYA TherapeuticsSubindustry Rankings in
BiotechnologyCity Rank
Share
Loading...
In Lausanne
Top null%out of exits
National Rank
Share
Loading...
In Switzerland
Top null%out of exits
Regional Rank
Share
Loading...
In Western Europe
Top null%out of exits
rankings by:
HAYA TherapeuticsSB Rank Evolution
Not enough data points to display the chart.
HAYA TherapeuticsexitComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro